Perivascular glial reactivity is a feature of phosphorylated tau lesions in chronic traumatic encephalopathy, 2025, Osterman, Murray et al

Discussion in 'Other health news and research' started by Hutan, Mar 11, 2025.

  1. Hutan

    Hutan Moderator Staff Member

    Messages:
    31,729
    Location:
    Aotearoa New Zealand
    https://pubmed.ncbi.nlm.nih.gov/39921702/

    Abstract

    Chronic traumatic encephalopathy (CTE), a neurodegenerative disease associated with repetitive head injuries, is characterised by perivascular hyperphosphorylated tau (p-tau) accumulations within the depths of cortical sulci. Although the majority of CTE literature focuses on p-tau pathology, other pathological features such as glial reactivity, vascular damage, and axonal damage are relatively unexplored.

    In this study, we aimed to characterise these other pathological features, specifically in CTE p-tau lesion areas, to better understand the microenvironment surrounding the lesion. We utilised multiplex immunohistochemistry to investigate the distribution of 32 different markers of cytoarchitecture and pathology that are relevant to both traumatic brain injury and neurodegeneration. We qualitatively assessed the multiplex images and measured the percentage area of labelling for each marker in the lesion and non-lesion areas of CTE cases.

    We identified perivascular glial reactivity as a prominent feature of CTE p-tau lesions, largely driven by increases in astrocyte reactivity compared to non-lesion areas. Furthermore, we identified astrocytes labelled for both NAD(P)H quinone dehydrogenase 1 (NQO1) and L-ferritin, indicating that lesion-associated glial reactivity may be a compensatory response to iron-induced oxidative stress. Our findings demonstrate that perivascular inflammation is a consistent feature of the CTE pathognomonic lesion and may contribute to the pathogenesis of brain injury-related neurodegeneration.
     
  2. Subtropical Island

    Subtropical Island Senior Member (Voting Rights)

    Messages:
    2,122
    Maybe a dumb question but what is ‘multiplex immunohistochemistry’?

    Are we talking about taking a sample of brain tissue out and staining it? Or are we talking about dosing someone/their brain with chemistry to then pick up in imaging? Does imaging mean CT/MRI or something else again?
    Or are these questions we’re not supposed to ask yet as it’s being developed?

    I’m just trying to imagine the sort of patient experience this might be if/when they get it available to contact sportspeople. And how different it might be from the imaging done when someone gets a significant concussion?
    And I’m honestly wondering about whether it will be prohibitively expensive or difficult to do even in 10yrs time. Thinking of the stat around prison populations and head injuries, it’s not just elite athletes who might benefit from this.
     

Share This Page